Ascribe Extends Integrated Pharmacy and Robotic IT Systems to Royal Bolton Hospital

Ascribe plc (AIM:ASP), the innovative health IT Group, today announced that it has successfully installed its Web Pharmacy solution at the Royal Bolton Hospital, part of the Bolton Hospitals NHS Trust and that the site is completely operational. One unique aspect of this 'Go Live' was that, on the same day that the hospital changed its pharmacy IT system, they also brought online a robotic dispensing system; thereby taking a massive leap forward in improving patient care and safety.

The Ascribe Web enabled pharmacy system is designed by healthcare clinicians to ensure higher patient safety standards. It achieves this by using a patient's medication record which effectively warns pharmacy staff automatically, via use of its integrated decision support service, if there may be a dangerous drug interaction or allergic reaction arising from the dispensed medications.

The Ascribe pharmacy system was selected by Bolton Hospital NHS Trust because it extends such a broad range of complementary pharmacy services outside of the dispensary. The system has been designed to allow ward-based clinical services, such as medicines management (whereby medicines can be ordered wirelessly from the wards) and electronic prescribing and medicine administration (which records exactly what medication was prescribed, when the medication was administered to the patient, and what reaction was noted). In addition to this, the Ascribe pharmacy system also provides the hospital pharmacy staff with a bi-directional interface from their pharmacy system to their Rowa Speedcase Robotic Dispensing unit, allowing pharmacists to both issue requests for prescriptions to their robotic system and receive (stock level) updates from their robot.

Brian Smith, Chief Pharmacist at the Royal Bolton Hospital said "The Bolton Hospitals NHS Trust is delighted that Ascribe was able to deliver such a robust and flexible pharmacy system within a twelve week project cycle. Our staff has welcomed the additional patient safety features that are embedded within the system and we look forward to extending our pharmacy services beyond the pharmacy itself, thereby saving time and providing a higher level of service to our clinicians and patients."

Stephen Critchlow, Executive Chairman of Ascribe plc said "Ascribe is delighted that the Royal Bolton has taken this step to improve patient safety standards. Our technology enables Hospitals to provide their clinicians with comprehensive and relevant information when and where healthcare decisions are made. This technology is in increasing demand and we have recently sold similar systems in the UK (at Addenbrookes Hospital, part of the Cambridge University Hospitals NHS Foundation Trust), and overseas in Australia & New Zealand."

For further information, please visit:
http://www.ascribe.com

About Ascribe
Ascribe plc is a leading healthcare company that develops and markets software solutions supporting patient, clinical and business processes to Primary & Secondary healthcare providers in the UK and overseas.

Ascribe is committed to providing technologies that improve patient safety standards and the company's solutions directly improve patient care and deliver financial savings to customers. The Group sells directly to hospitals and Primary Care Trusts rather than through centrally driven political initiatives.

The Group provides solutions to clinical professionals in all healthcare sectors; customers include Emergency and Minor Injuries Units, Mental Health and Social Care Units, Hospitals requiring patient administration systems (PAS) and medical equipment management, Hospital and Retail Pharmacies, and General Practice surgeries. Offering patient and decision support information to these clinicians in context with their activity is the key to the company's ongoing success.

Ascribe plc was floated on AIM in 2004, and currently employs over 220 personnel through its operating companies in the UK, Kenya, Australia and New Zealand.

For more information, please visit www.ascribe.com.

About Bolton Hospitals NHS Trust
Bolton Hospitals NHS Trust offers patients a wide range of services based at the Royal Bolton Hospital as well as some which take place in community settings. It is the Trust's aim to have the best hospital in the NHS by providing best possible care for our patients, improved health for local people, and joy and pride in work for our staff. Bolton Hospitals NHS Trust was formed in April 1994 and now serves the population of Bolton (around 265,000) plus some neighbouring areas. The Trust employs over 3,100 staff.

Most Popular Now

Pfizer and BioNTech complete submission to Europea…

Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced they have completed a submission to the European Medicines Agency (EMA) for an Omicron-adapted biva...

Lilly will supply an additional 150,000 doses of b…

Eli Lilly and Company (NYSE: LLY) announced a modified purchase agreement with the U.S. government to supply an additional 150,000 doses of bebtelovimab for approximately...

Bayer to sell men's health product Nebido™ to Grün…

Bayer and Grünenthal have entered into a definitive agreement regarding the sale of Bayer's men's health product Nebido™ (testosterone undecanoate), for a purchase price ...

AstraZeneca to acquire TeneoTwo and its clinical-s…

AstraZeneca announced an agreement to acquire TeneoTwo, Inc. (TeneoTwo)i, including its Phase I clinical-stage CD19/CD3 T-cell engager, TNB-486, currently under evaluatio...

Demonstration of a potent, universal coronavirus m…

The SARS-CoV-2 that causes COVID-19 has killed 6.3 million people worldwide since 2019, painfully highlighting the vulnerability of humanity to novel coronaviruses. Re...

The fourth COVID-19 vaccine reduces the risk of de…

A new study by Tel Aviv University and Ben Gurion University of the Negev, in collaboration with the Israeli Ministry of Health, has found that the fourth COVID-19 vaccin...

Vaccine protection against COVID-19 short-lived, b…

Since COVID-19 vaccines first became available to protect against infection and severe illness, there has been much uncertainty about how long the protection lasts, and w...

Research shows investigational drug fosters nerve …

Scientists from the University of Birmingham have shown that a brain-penetrating candidate drug currently in development as a cancer therapy can foster regeneration of da...

NIH launches clinical trial of mRNA Nipah virus va…

The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, has launched an early-stage clinical trial evaluating an inv...

Anti-inflammatory compound shows potential in trea…

An anti-inflammatory compound may have the potential to treat systemic inflammation and brain injury in patients with severe COVID-19 and significantly reduce their chanc...

Vaccine-induced immune response to omicron wanes s…

Although COVID-19 booster vaccinations in adults elicit high levels of neutralizing antibodies against the Omicron variant of SARS-CoV-2, antibody levels decrease substan...

SARS-CoV-2 hijacks nanotubes between neurons to in…

COVID-19 often leads to neurological symptoms, such as a loss of taste or smell, or cognitive impairments (including memory loss and concentration difficulties), both dur...